Drug Type Biological products |
Synonyms |
Target |
Mechanism NRAS inhibitors(GTPase NRas inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization Pharos iBio Co., Ltd.Startup |
Active Organization Pharos iBio Co., Ltd.Startup |
Inactive Organization- |
Drug Highest PhaseIND Application |
First Approval Date- |
RegulationOrphan Drug (US) |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Colonic Cancer | IND Application | KR | Pharos iBio Co., Ltd.Startup | 30 Jul 2024 |
Melanoma | IND Application | KR | Pharos iBio Co., Ltd.Startup | 30 Jul 2024 |
Triple Negative Breast Cancer | IND Application | KR | Pharos iBio Co., Ltd.Startup | 30 Jul 2024 |
Acute Myeloid Leukemia | Discovery | KR | Pharos iBio Co., Ltd.Startup | 03 Dec 2021 |